Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Issue: Sep/Oct 2012 - Volume 16, Number 5
View All Articles in Issue
Page(s): 431-433
Download in electronic PDF format for $75
Abstract: PhaSeal is a closed-system drug transfer device which has demonstrated to protect against occupational exposure to antineoplastic agents. Our aim was to assess the impact of the incorporation of PhaSeal on the processing time of chemotherapy. The study was a prospective simulation study which compared the processing times with the traditional open-system technique and using the closed-transfer system. Four experienced pharmacy technicians prepared six batches with each method simulating simple chemotherapy admixture operations. We compared the mean times obtained by student's t test and evaluated the “learning effect” between days by ANOVA. The average percentage of time saving with PhaSeal was 31.7% (time per batch [mean±SD] 6.44+0.73 vs. 9.44+0.98 minutes). Mean difference was statistically significant (3.0 min IC95% 2.50-3.50; p>0.0001). No significant learning curve effect was detected. The BD Medical/Carmel Pharma PhaSeal system, in addition to its protective properties, is able to save time in the elaboration process which leads to organization advantages for hospital pharmacy services.
Related Keywords:
closed-system drug transfer, chemotherapy agents, occupational exposure, preparation time
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
|
Sep/Oct 2012
Pg. 431-433
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
|
Jan/Feb 2022
Pg. 72-79
|
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
|
Nov/Dec 2021
Pg. 515-522
|
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal, Rios GL Quito
|
Sep/Oct 2022
Pg. 358-362
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke, Crul Mirjam, Breukels Oscar
|
Mar/Apr 2023
Pg. 154-159
|
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen, Giuliano Karen, Middleton Aurea
|
Mar/Apr 2023
Pg. 169-174
|
Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 126-129
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015
Pg. 30-37
|
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
|
Nov/Dec 2012
Pg. 446-450
|
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
|
Jul/Aug 2023
Pg. 340-346
|
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018
Pg. 108-121
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
Return to Top |